These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9424761)

  • 1. [The angiotensin-converting enzyme inhibitor perindopril in the treatment of congestive heart failure].
    Tereshchenko SN; Drozdov VN; Demidova IV; Levchuk NN; Moiseev VS
    Ter Arkh; 1997; 69(7):53-6. PubMed ID: 9424761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Change of circadian pattern of arterial pressure in patients with congestive heart failure treated with perindopril, an inhibitor of angiotensin-converting enzyme (ACE)].
    Tereshchenko SN; Kobalova ZhD; Demidova IV; Moiseev VS
    Ter Arkh; 1997; 69(12):40-3. PubMed ID: 9503533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acute effect of perindopril upon effort capacity in congestive heart failure.
    Zdrenghea D; Angheloiu O; Icusca G; Timiş D
    Rom J Intern Med; 1994; 32(4):265-9. PubMed ID: 7613498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
    Sami MH
    Can J Cardiol; 1994 Nov; 10 Suppl D():13D-16D. PubMed ID: 7954033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polymorphism of the ACE gene, structural-functional state of the left ventricle in patients with post-infarction cardiac failure and effects of the ACE-inhibitor Perindopril].
    Tereshchenko SN; Demidova IV; Kobalava ZhD; Moiseev VS
    Ter Arkh; 2002; 74(4):56-8. PubMed ID: 12043242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral haemodynamic effects of perindopril compared in patients with congestive heart failure and in normal volunteers.
    Thuillez C; Richard C; Richer C; Loueslati H; Perret L; Auzépy P; Giudicelli JF
    J Hypertens Suppl; 1988 Dec; 6(3):S41-3. PubMed ID: 2852235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
    Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C; Ciliberti P; Graziosi M; Riva L
    Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gopten (trandolapril) in the treatment of chronic heart failure in patients with ischemic heart disease].
    Kakhnovskiĭ IM; Fomina IG; Ostroumov EL; Lepeshkov VM; Gaĭdamakina NE; Kaveshnikova OV; Markova ZS; Lugovaia EL
    Ter Arkh; 1998; 70(8):29-33. PubMed ID: 9770740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The long-term administration of perindopril improves the hemodynamic status of rats with heart failure].
    Medvedev OS; Zakharova NV
    Eksp Klin Farmakol; 1994; 57(6):26-9. PubMed ID: 7756952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perindopril and chronic heart failure].
    Bounhoure JP
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():89-92. PubMed ID: 1793331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of perindopril in pacing-induced canine models of acute and chronic heart failure.
    Ogilvie RI; Zborowska-Sluis D
    Can J Cardiol; 1995 Nov; 11(10):934-40. PubMed ID: 7489534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: a Malaysian experience.
    Navookarasu NT; Rahman AR; Abdullah I
    Int J Clin Pract; 1999; 53(1):25-30. PubMed ID: 10344062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of prestarium in patients with chronic heart failure].
    Abashidze TB; Lortkipanidze RM
    Georgian Med News; 2005 Dec; (129):54-7. PubMed ID: 16444031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure].
    Song HM; Zhang J; Deng B; Luo M
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1737-40. PubMed ID: 16253158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of perindopril in the treatment of chronic congestive heart failure. Multicenter double-blind placebo-controlled study.
    Bounhoure JP; Bottineau G; Lechat P; Garnham J; Lapeyre G
    Clin Exp Hypertens A; 1989; 11 Suppl 2():575-86. PubMed ID: 2691130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The perindopril in elderly people with chronic heart failure (PEP-CHF) study.
    Cleland JG; Tendera M; Adamus J; Freemantle N; Polonski L; Taylor J;
    Eur Heart J; 2006 Oct; 27(19):2338-45. PubMed ID: 16963472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
    Sami M
    Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma hemostasis and biochemical indices in trimetazidine treatment of patients with chronic heart failure].
    Tereshchenko SN; Drozdov VN; Levchuk NN; Demidova IV
    Ter Arkh; 1998; 70(6):41-4. PubMed ID: 9695225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.